Genetic testing program pioneered in Maritimes improving cancer care in Canada

A genetic testing program pioneered in the Maritimes is significantly improving cancer care across Canada, according to global news. Ryan White credits the IWK Maritime Centre for Precision Medicine in Halifax for saving his life after he was diagnosed with a rare form of leukemia, acute myeloid leukemia. The testing helps rule out a stem-cell donor with a genetic risk for developing leukemia, which was crucial in White's case.

The testing, part of Canada's first clinical program focused on hereditary myeloid malignancies, was developed by hematologist Dr. Amy Trottier. Trottier explains that in White's case, the testing revealed a hereditary predisposition for the cancer, explaining why his leukemia returned despite going into remission. This information allowed for the identification of an alternative donor and a tailored treatment plan based on White's unique genetic factors.

IWK Health is one of only two centers in Canada offering this specialized testing, and has become a referral center for the rest of the country. For White, the access to this testing was life-changing, and he credits the IWK team for helping him have this opportunity.